Journal profile

Orphanet journal of rare diseases

Publisher: BioMed Central
ISSN1750-1172 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.16
Citation rate 4.45 3,789 total citations
h5-index 62 h5 depth signal
Cited share 87.1% 774 of 889
Total citations 3,789 Citation footprint
Metric signal 4.15 External metric anchor
Self-citation 5.9% 222 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

China 924
United States 921
United Kingdom 642
Germany 607
France 582

Citing Fields of Research

Lysosomal Storage Disorders 585
Musculoskeletal Disorders 534
Genetics & Genomics 502
Congenital Disorders 484
Cytogenetics 372

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 5,524 Articles tracked across the journal lifetime
Indexed publication set 889 774 cited publications
Last 12 months 609 50.8 publications/month
Open access share 100.0% 609 OA publications in the last year
Leading citing country China 924 citing publications
Leading citing field Lysosomal Storage Disorders 585 citing publications
Latest tracked publication 20 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, Mar. 1, 2006-
PubMed
v1n1, Mar. 1, 2006-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Lysosomal Storage Disorders Musculoskeletal Disorders Genetics & Genomics Hematology Auto-Inflammatory Disorders Congenital Disorders Cytogenetics

Broad Categories

Medicine Lysosomal Storage Disorders Mitochondria Medical Ethics Musculoskeletal Disorders Cytogenetics Hematology Cell Differentiation & Development

MeSH Descriptors

Orphan Drug Production Rare Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Zhuang Tian, Daoquan Peng, Wei Ma et al.
Background: A multicenter, open-label, post-approval commitment study previously demonstrated the safety and efficacy of tafamidis in Chinese patients with transthyretin amyloid cardiomyopathy (ATTR-CM). This post hoc analysis evaluated ...
06
Zamora-Crespo Berta, Moreno-Ramos Zaida, Martínez de Aragón Ana et al.
Background: This study aimed to characterize the neurocognitive and neuroradiological profiles of children and young adults with Glutaric Aciduria Type 1 (GA-1) included in the Spanish National GA-1 Registry and to examine the associatio...
07
Ming Wu, Shuyuan Zhang, Yang Lu et al.
Background: Transthyretin (TTR) cardiac amyloidosis (ATTR-CA) is an underdiagnosed cause of heart failure, resulting from the deposition of misfolded TTR in the myocardium. We investigated the diagnostic and prognostic value of circulati...

Bibliographical & Catalog Notes

Title from PDF caption (publisher's Web site, viewed Mar. 17, 2006).

Latest issue consulted: 1:4 (13 Mar. 2006) (viewed Mar. 17, 2006).

Articles added consecutively to current annual v.

Mode of access: Internet.